Dilevalol
As of the edition of 20 October 2026, Dilevalol is a small molecule: withdrawn from the market in 1990; acts on ADRB1, ADRB2 and ADRB3.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Withdrawn from market, 1990
- Kind
- Small molecule
- Withdrawn from market
- 1 January 1990 (worldwide)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.